Filing Details

Accession Number:
0000905148-17-000939
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-15 18:38:49
Reporting Period:
2017-12-15
Accepted Time:
2017-12-15 18:38:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358762 Reata Pharmaceuticals Inc RETA Pharmaceutical Preparations (2834) 113651945
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1372218 Cpmg Inc 2000 Mckinney Ave., Ste 2125
Dallas TX 75201
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2017-12-13 19,982 $24.88 462,542 No 4 P Indirect By Gallopavo, LP
Class A Common Stock Acquisiton 2017-12-13 49 $23.98 462,591 No 4 P Indirect By Gallopavo, LP
Class A Common Stock Acquisiton 2017-12-14 14,866 $24.65 477,457 No 4 P Indirect By Gallopavo, LP
Class A Common Stock Acquisiton 2017-12-13 31,471 $24.88 728,503 No 4 P Indirect By Roadrunner Fund, LP
Class A Common Stock Acquisiton 2017-12-13 78 $23.98 728,581 No 4 P Indirect By Roadrunner Fund, LP
Class A Common Stock Acquisiton 2017-12-14 19,672 $24.65 748,253 No 4 P Indirect By Roadrunner Fund, LP
Class A Common Stock Acquisiton 2017-12-13 9,990 $24.88 96,915 No 4 P Indirect By Blackwell Partners LLC
Class A Common Stock Acquisiton 2017-12-13 25 $23.98 96,940 No 4 P Indirect By Blackwell Partners LLC
Class A Common Stock Acquisiton 2017-12-14 6,245 $24.65 103,185 No 4 P Indirect By Blackwell Partners LLC
Class A Common Stock Acquisiton 2017-12-13 59,982 $24.88 393,515 No 4 P Indirect By Yellow Warbler, LP
Class A Common Stock Acquisiton 2017-12-13 148 $23.98 393,663 No 4 P Indirect By Yellow Warbler, LP
Class A Common Stock Acquisiton 2017-12-14 37,492 $24.65 431,155 No 4 P Indirect By Yellow Warbler, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Gallopavo, LP
No 4 P Indirect By Gallopavo, LP
No 4 P Indirect By Gallopavo, LP
No 4 P Indirect By Roadrunner Fund, LP
No 4 P Indirect By Roadrunner Fund, LP
No 4 P Indirect By Roadrunner Fund, LP
No 4 P Indirect By Blackwell Partners LLC
No 4 P Indirect By Blackwell Partners LLC
No 4 P Indirect By Blackwell Partners LLC
No 4 P Indirect By Yellow Warbler, LP
No 4 P Indirect By Yellow Warbler, LP
No 4 P Indirect By Yellow Warbler, LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 110,640 Indirect By Killdeer Fund, LP
Class A Common Stock 109,415 Indirect By Mallard Fund, LP
Class A Common Stock 280,500 Indirect By Willet Fund, LP
Class A Common Stock 37,909 Indirect By Crested Crane, LP
Class A Common Stock 63,481 Indirect By Flamingo Fund, LP
Class A Common Stock 334,740 Indirect By Sandpiper Fund, LP
Class A Common Stock 160,265 Indirect By Kestrel Fund, LP
Class A Common Stock 11,076 Indirect By CD Fund, LP
Class A Common Stock 134 Indirect By Redbird Life Sciences Partners, LP
Class A Common Stock 113 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Class A Common Stock Class B Common Stock $0.00 150,186 150,186 Indirect
Class A Common Stock Class B Common Stock $0.00 307,776 307,776 Indirect
Class A Common Stock Class B Common Stock $0.00 123,379 123,379 Indirect
Class A Common Stock Class B Common Stock $0.00 1,490 1,490 Indirect
Class A Common Stock Class B Common Stock $0.00 1,251 1,251 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
150,186 150,186 Indirect
307,776 307,776 Indirect
123,379 123,379 Indirect
1,490 1,490 Indirect
1,251 1,251 Direct
Footnotes
  1. This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $24.08 to $25.08 inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
  2. This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $23.97 to $23.99 inclusive.
  3. This price reflects the weighted average purchase price for open-market purchases on December 14, 2017, within a $1.00 range. The actual prices for these transactions range from $24.40 to $24.92, inclusive.
  4. These shares of Class B common stock are convertible into Class A common stock on a one-for-one basis at the holder's election at any time for no additional consideration, and have no expiration date.
  5. The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.